Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 34996412

Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
BMC Cancer
Publication date
2022 Jan 8
First author
Lau-Min KS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Lau-Min KS
      type
      Author
    2. name
      Varughese LA
      type
      Author
    3. name
      Nelson MN
      type
      Author
    4. name
      Cambareri C
      type
      Author
    5. name
      Reddy NJ
      type
      Author
    6. name
      Oyer RA
      type
      Author
    7. name
      Teitelbaum UR
      type
      Author
    8. name
      Tuteja S
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Lau-Min KS
      type
      Author
    2. name
      Varughese LA
      type
      Author
    3. name
      Nelson MN
      type
      Author
    4. name
      Cambareri C
      type
      Author
    5. name
      Reddy NJ
      type
      Author
    6. name
      Oyer RA
      type
      Author
    7. name
      Teitelbaum UR
      type
      Author
    8. name
      Tuteja S
      type
      Author
    bibliography ids
    1. nci-bib-24fb284f16740dcb97e19fca
    book metadata
    content sha256
    92c4ef76290725951177d6059a19ebf84ca6f3d74701b8c6ee4222c103ba5981
    document type
    citation
    dois
    1. 10.1186/s12885-022-09171-6
    electronic publication date
    display
    2022 Jan 8
    precision
    day
    year
    2022
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:34996412
    immutable id
    pubmed:34996412@92c4ef76290725951177d6059a19ebf84ca6f3d74701b8c6ee4222c103ba5981
    journal
    abbreviation
    BMC Cancer
    issn electronic
    1471-2407
    issn print
    Source null
    issue
    1
    name
    BMC cancer
    nlm unique id
    100967800
    pages
    47
    volume
    22
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      34996412
      provenance
      batch id
      3f4d1914d2afe41e9e70
      provider
      NCBI PubMed ESummary
      record sha256
      613caffb2246f11bb76ed88335547b1736800018b69a366561e4144795c0a9a3
      response sha256
      0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
      retrieved at
      2026-09-09T23:48:06.522634+00:00
      publication date
      display
      2022 Jan 8
      precision
      day
      year
      2022
      publication types
      1. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/34996412/
      title
      Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.

      Preserved source evidence · Independent clinical review pending · Not medical advice